Link to this page
PMO Precision Medicine Ontology
Last uploaded:
December 16, 2020
Jump to:
Preferred Name | Telavancin | |
Synonyms |
|
|
ID |
http://www.phoc.org.cn/pmo/class/PMO_00026048 |
|
Database_Cross_Reference |
MTH:NOCODE MSH:C487637 NDFRT:N0000180310 RXNORM:473837 NCI_FDA:XK134822Z0 MMSL:d07483 SNOMEDCT_US:443553004 ATC:J01XA03 NCI:C87603 LNC:LP158089-5 DRUGBANK:DB06402 USPMG:MTHU002213 MTHSPL:XK134822Z0 SNOMEDCT_US:443552009 LNC:MTHU045743 MMSL:26725 NDDF:013290 VANDF:4029465
|
|
label |
Telavancin
|
|
MCID |
MC00518877
|
|
PMOID |
PMO:00026048
|
|
prefixIRI |
pmo:PMO_00026048
|
|
prefLabel |
Telavancin
|
|
Synonym |
telavancin Telavancina Telavancin (product) Télavancine Telavancinum Telavancin (substance) (1S,2R,18R,19R,22S,25R,28R,40S)-22-(2-amino-2-oxoethyl)-5,15-dichloro-48-{[(2S,3R,4S,5S,6R)-3-{[(2S,4S,5S,6S)-4-{[2-(decylamino)ethyl]amino}-5-hydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}-2 Vancomycin, N(Sup 3'')-(2-(Decylamino)Ethyl)-29-(((Phosphonomethyl)Amino)Methyl)- TELAVANCIN
|
|
Tree Number |
T6.4.2.2.2.3.3
|
|
subClassOf |
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |
Create mapping